More Business Wire
View Older Stories View Newer Stories-
VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore
-
FCA-Authorised Digital Asset Derivatives Venue GFO-X Raises $30m Series B Funding, Led by M&G Investments
-
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
-
Morrow Sodali Acquires Australian Corporate Communication Consultancy, Domestique
-
Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B
-
Hudson’s Bay Workers in Kamloops Take Strike Action
-
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independ
-
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
-
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
-
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
-
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH
-
Teoayeah’s Christmas Gift List for All Kids (12/11-12/24)
-
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
-
Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation
-
Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
-
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
-
Bristol Myers Squibb Presents Primary Efficacy and Safety Analysis of the Phase 3 COMMANDS Trial of Reblozyl for Treatment of Anemia in Erythropoiesis Stimulating Agent-Naïve Patients with Lower-Risk
-
Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma
-
Rallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual Meeting
-
Port Houston Regular Commission Meeting
-
Long-term Follow-up Data From bluebird’s Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Re
-
New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A
-
AYA Platform of Enjinstarter Granted Virtual Asset Service Provider Licence by Dubai’s Virtual Assets Regulatory Authority
-
Revolutionizing Water Stewardship – The City of Dire Dawa and Nedamco Africa Unveil Cutting-Edge Water Management Platform Initiative at COP28 | December 9th 2023 | COP28UAE Press Center
-
Air Force's Trey Taylor Named 2023 Paycom Jim Thorpe Award Winner
-
Newmont Announces Successful Early Tender Results for the Exchange Offers and Consent Solicitations
-
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Niman Ranch Statement on FDA Report Showing Rising Antibiotic Use for Livestock
-
Maritime Launch Announces Closing of Non-Brokered Private Placement of Convertible Debentures
-
Utah Attorney General Sean Reyes’ Statement on Decision to Not Seek Re-election in 2024
-
How to Subscribe to Core Scientific’s Equity Rights Offering
-
PBCO Financial Corporation Announces Securities Portfolio Repositioning
-
Unit Corporation Declares Quarterly and Special Cash Dividends
-
Bob’s Discount Furniture Wins Furniture Today’s “Furniture Industry Leadership” Award
-
KBRA Assigns Preliminary Ratings to APL Finance 2023-1 Designated Activity Company
-
AM Best Affirms Credit Ratings of Lincoln National Corporation and Its Subsidiaries
-
Halliburton Fourth Quarter 2023 Earnings Conference Call
-
Manchester United and MLILY Extend Global Partnership
-
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
-
KBRA Assigns Chicago Midway International Airport Senior Lien GARBs A, Stable Outlook; Affirms Second Lien Bonds
-
Martin Houston Becomes Chairman of Tellurian Inc.
-
Community Health Systems, Inc. Provides Notice of Proposed Derivative Settlement
-
AM Best Places Credit Ratings of Mt. Morris Mutual Insurance Company Under Review With Developing Implications
-
Edgio Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
-
Pivotree Announces Annual Grant of Equity Incentive Plan Awards
-
State Street Corporation (NYSE: STT) Announces Date for Release of Fourth-Quarter and Full-Year 2023 Financial Results and Conference Call Webcast
-
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AM Best Revises Outlooks to Positive, Affirms Credit Ratings of Grupo Aserta S.A.P.I. de C.V. and Its Main Subsidiaries
-
Albany International Declares Dividend
-
CB Financial Services, Inc. Completes Sale of Insurance Agency Subsidiary
